Stay updated on Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.

Latest updates to the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.3 appears in the page header. The footer updates remove HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check39 days agoChange DetectedThe record history shows an added system revision v3.3.1 and a removed revision v3.2.0.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding notice about data currency and operating status was removed from the page. The remainder of the page content and the study history table remain unchanged.SummaryDifference0.4%

- Check61 days agoChange DetectedThe version history shows updates to Study Status and Contacts/Locations across several versions, reflecting changes in recruitment status and site locations.SummaryDifference0.1%

- Check89 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed old v3.1.0 label.SummaryDifference9%

Stay in the know with updates to Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.